SCHEMBL413500

SCHEMBL413500

CP(C)(=O)OCCC#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27689138 0.85 PKM (0.36) —
SCHEMBL27689139 0.81 — —
SCHEMBL11237347 0.79 — —
SCHEMBL733409 0.79 ALDH1A1 (0.43) —
SCHEMBL28068076 0.78 TSHR (0.39) —
SCHEMBL29285234 0.78 TSHR (0.50) —
SCHEMBL29285237 0.77 — —
SCHEMBL11907935 0.76 CYP3A4 (0.34) —
SCHEMBL23772196 0.75 — —
SCHEMBL497349 0.75 P2RY14 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8981076-B2 Synthesis of N-FMOC protected deoxy nucleosides, ribo nucleosides, modified deoxy and ribo nucleosides, and phosphoramidites, and their use in oligonucleotide synthesis CHEMGENES CORPORATION (US) 2015-03-17 — — US disclosed
US-8541569-B2 Phosphoramidites for synthetic RNA in the reverse direction, efficient RNA synthesis and convenient introduction of 3'-end ligands, chromophores and modifications of synthetic RNA CHEMGENES CORPORATION (US) 2013-09-24 — — US disclosed
US-20130137861-A1 NOVEL METHODS FOR THE SYNTHESIS AND PURIFICATION OF OLIGOMERS AGILENT TECHNOLOGIES, INC. (US) 2013-05-30 — — US disclosed
US-8431693-B2 Process for desilylation of oligonucleotides ALNYLAM PHARMACEUTICALS, INC. (US) 2013-04-30 — — US disclosed
US-20120065386-A1 SYNTHESIS OF LABILE BASE PROTECTED - MODIFIED DEOXY &amp; MODIFIED RIBO NUCLEOSIDES, CORRESPONDING PHOSPHORAMIDITES AND SUPPORTS AND THEIR USE IN HIGH PURITY OLIGONUCLEOTIDE SYNTHESIS CHEMGENES CORPORATION 2012-03-15 — — US disclosed
US-8063198-B2 Processes and reagents for desilylation of oligonucleotides ALNYLAM PHARMACEUTICALS, INC. (US) 2011-11-22 — — US disclosed
US-8058448-B2 Processes and reagents for sulfurization of oligonucleotides ALNYLAM PHARMACEUTICALS, INC. (US) 2011-11-15 — — US disclosed
US-20110196145-A1 PROCESS FOR DESILYLATION OF OLIGONUCLEOTIDES ALNYLAM PHARMACEUTICALS, INC. (US) 2011-08-11 — — US disclosed
US-20110137010-A1 PHOSPHORAMIDITES FOR SYNTHETIC RNA IN THE REVERSE DIRECTION, EFFICIENT RNA SYNTHESIS AND CONVENIENT INTRODUCTION OF 3'-END LIGANDS, CHROMOPHORES AND MODIFICATIONS OF SYNTHETIC RNA CHEMGENES CORPORATION (US) 2011-06-09 — — US disclosed
US-20110015382-A1 Synthesis of N-FMOC protected deoxy nucleosides, ribo nucleosides, modified deoxy and ribo nucleosides, and phosphoramidites, and their use in oligonucleotide synthesis CHEMGENES CORPORATION (US) 2011-01-20 — — US disclosed
US-20090187027-A1 PROCESSES AND REAGENTS FOR SULFURIZATION OF OLIGONUCLEOTIDES ALNYLAM PHARMACEUTICALS, INC. (US) 2009-07-23 — — US disclosed
US-20090005549-A1 Processes and Reagents for Desilylation of Oligonucleotides ALNYLAM PHARMACEUTICALS, INC. (US) 2009-01-01 — — US disclosed
Send feedback